Vizz (Lenz Therapeutics) is the first and only aceclidine-based eye drop for presbyopia and is also the first daily solution ...

Discover how patient-centred design transforms inclusive clinical trials. Learn to overcome trial recruitment challenges by ...

Contact lenses are thin, clear, rounded disks with curved edges placed directly on the surface of the eye. According to ...

Roche’s Genentech has reported new five-year data from the Phase III Portal trial, confirming the safety, durability, and ...

LUCIA pivotal Phase 3 trial enrolled and randomized over 400 patients in seven months, demonstrating continued strong enthusiasm for the DURAVYU pivotal program across the global retinal community – – ...

VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia, a condition ...

New findings reveal Syfovre may protect central vision in macular degeneration patients, delaying vision loss and enhancing treatment strategies.

Hundreds of clinical trials and digital studies are conducted each year by Sutter Health to better understand, detect, treat ...

As AI technology increasingly amalgamates into the medical arena, health system leaders are stepping up to help steer the path forward. Women comprise only 30% of those working in AI today, and ...

LUCIA pivotal Phase 3 trial enrolled and randomized over 400 patients in seven months, demonstrating continued strong enthusiasm for the DURAVYU pivotal program across the global retinal community ...

D-150 continues to be well tolerated with no intraocular inflammation observed at any timepoint or dose level4D-150 demonstrated durable and dose-dependent clinical activity with sustained gains in ...